Parmax Pharma informs about board meeting outcome

12 Nov 2022 Evaluate

Parmax Pharma has informed about Outcome of the Board meeting and approval of Unaudited Financial statements for quarter and half year ended 30th September, 2022.

The above information is a part of company’s filings submitted to BSE.

Parmax Pharma Share Price

35.04 0.52 (1.51%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×